Product Information
IMIPRAMINE HCL 25 MG TABLET is a generic product labeled by Oxford Pharmaceuticals, LLC, priced at $0.0912 per EA under NDC 69584042610. Its NADAC has been published 243 times since Dec 29, 2021.
FDA first approved this application on Feb 28, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Oxford Pharmaceuticals, LLCNDC
69584042610
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040751FDA Approved
2/28/2008
TE Code
AB
On Market Since
8/1/2020
Pharmacological Classes
Price Statistics
The NADAC for IMIPRAMINE HCL 25 MG TABLET has been published 243 times since Dec 29, 2021, and over the history we have for it it has declined 6.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0912 per EA |
|---|---|
| All-time high | $0.1074 (Jun 15, 2022) |
| All-time low | $0.0746 (Nov 20, 2024) |
| 52-week high | $0.0912 |
| 52-week low | $0.0806 |
| Median price | $0.0913 |
| Average price | $0.0916 |
| Largest weekly change | +27.4% (Mar 20, 2024) |
| Weeks tracked | 243 |
| Tracking since | Dec 29, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IMIPRAMINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IMIPRAMINE HCL 25 MG TABLET, manufactured by Oxford Pharmaceuticals, LLC, is $0.0912 per EA (NDC 69584042610), effective Aug 19, 2026.
How has the price of IMIPRAMINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for IMIPRAMINE HCL 25 MG TABLET has declined 6.1%. It has been tracked across 243 weekly CMS publications since Dec 29, 2021.
What are the highest and lowest recorded NADAC prices for IMIPRAMINE HCL 25 MG TABLET?
Since Dec 29, 2021, the NADAC for IMIPRAMINE HCL 25 MG TABLET has ranged from a low of $0.0746 (Nov 20, 2024) to a high of $0.1074 (Jun 15, 2022), with a median of $0.0913 per EA.
Are there cheaper alternatives to IMIPRAMINE HCL 25 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IMIPRAMINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IMIPRAMINE HCL 25 MG TABLET?
IMIPRAMINE HCL 25 MG TABLET (NDC 69584042610) is labeled by Oxford Pharmaceuticals, LLC, and CMS classifies it as a generic product.